KCTD11

Potassium Channel Tetramerization Domain Containing 11: A Tumor Suppressor in Medulloblastoma

Gene Information Card

Symbol KCTD11
Full Name Potassium Channel Tetramerization Domain Containing 11
Gene Type Protein coding
Chromosomal Location 17p13.2
NCBI Gene ID 147040 ncbi.nlm.nih.gov/gene/147040
Ensembl ID ENSG00000178904
UniProt ID Q8N5K1
OMIM ID 609778
HGNC ID 21304
Aliases KCASH1, REN, KCTD11

Description

KCTD11 (potassium channel tetramerization domain containing 11), also known as KCASH1 or REN, is a protein-coding gene located on chromosome 17p13.2. It functions as a tumor suppressor, particularly in medulloblastoma, by negatively regulating the Hedgehog signaling pathway. KCTD11 promotes the degradation of the transcription factor GLI1, thereby inhibiting cell proliferation and tumor growth. The gene is frequently deleted or downregulated in medulloblastoma and other cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Medulloblastoma KCTD11 loss leads to increased GLI1 stability and aberrant Hedgehog signaling, promoting tumorigenesis. PMID: 15156142, PMID: 18772397
Hepatocellular carcinoma Reduced KCTD11 expression correlates with poor prognosis and enhanced proliferation via Hedgehog pathway activation. PMID: 23361061
Colorectal cancer KCTD11 downregulation is associated with tumor progression and metastasis. PMID: 25605247

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 5.2 Medium
Cerebellum 6.8 Medium
Testis 3.1 Low
Lung 1.5 Low
Liver 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
DAOY (medulloblastoma) 0.3 Low expression; loss of KCTD11 contributes to Hedgehog pathway activation
HEK293 4.5 Moderate expression; used for functional studies
HepG2 (liver cancer) 1.2 Reduced expression compared to normal hepatocytes
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Potential loss of start codon; likely loss of function
c.187C>T (p.Arg63Trp) Missense <0.1% Unknown significance; reported in COSMIC
Deletion of 17p13.2 Copy number loss Common in medulloblastoma Loss of heterozygosity; reduces KCTD11 expression
Mutation functional classification

Loss of Function (LOF)

Deletions and missense mutations that impair KCTD11's ability to degrade GLI1 are classified as loss-of-function, contributing to Hedgehog pathway overactivation.

Gain of Function (GOF)

No gain-of-function mutations have been reported for KCTD11.

Dominant Negative (DN)

No dominant-negative mutations have been described for KCTD11.

Gene Ontology (GO)

• Negative regulation of transcription by RNA polymerase II • Protein ubiquitination
• Hedgehog signaling pathway • Cytoplasm
• Nucleus

Pathways

• Hedgehog signaling pathway (Reactome: R-HSA-5358351)
• GLI1 degradation via ubiquitin-proteasome system

Protein Summary

KCTD11 encodes a 232-amino acid protein containing a BTB/POZ domain and a potassium channel tetramerization domain. It acts as an adaptor for Cullin3-based E3 ubiquitin ligase complexes, targeting GLI1 for ubiquitination and proteasomal degradation. This negative regulation of the Hedgehog pathway is critical for suppressing medulloblastoma growth. KCTD11 is predominantly cytoplasmic but can shuttle to the nucleus.

Related Products

Product name Cat.No. Species Gene ID
KCTD11 Knockout HEK293 Cell Line EDJ-KQ10545 Human 147040 Details Get a Quote
KCTD11 Knockout A-549 Cell Line EDJ-KQ37987 Human 147040 Details Get a Quote
KCTD11 Knockout HCT 116 Cell Line EDJ-KQ37988 Human 147040 Details Get a Quote
KCTD11 Knockout HeLa Cell Line EDJ-KQ37989 Human 147040 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: